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Abstract This review focuses on how measured pre- and
perinatal environmental and (epi)genetic risk factors are
interrelated and potentially influence one, of many, com-
mon developmental pathway towards ADHD. Consistent
with the Developmental Origins of Health and Disease
hypothesis, lower birth weight is associated with increased
ADHD risk. Prenatal ischemia-hypoxia (insufficient blood
and oxygen supply in utero) is a primary pathway to lower
birth weight and produces neurodevelopmental risk for
ADHD. To promote tissue survival in the context of
ischemia-hypoxia, ischemia-hypoxia response (IHR) path-
way gene expression is altered in the developing brain and
peripheral tissues. Although altered IHR gene expression is
adaptive in the context of ischemia-hypoxia, lasting IHR
epigenetic modifications may lead to increased ADHD risk.
Taken together, IHR genetic vulnerability to ischemia-hy-
poxia and IHR epigenetic alterations following prenatal
ischemia-hypoxia may result in neurodevelopmental
vulnerability for ADHD. Limitations of the extant literature
and future directions for genetically-informed research are
discussed.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a
chronic health condition characterized by persistent, per-
vasive, and developmentally inappropriate levels of inat-
tention, hyperactivity-impulsivity, or both (American
Psychiatric Association 2013). ADHD has an average
prevalence rate of 5–5.5 % in youth (Polanczyk et al.
2007), is more common in males (Polanczyk et al. 2007),
and generally persists into adulthood (Barbaresi et al.
2013). It is also associated with high rates of psychiatric
comorbidity (Angold et al. 1999). The economic impact of
ADHD in the United States is an estimated $143–$266
billion annually (Doshi et al. 2012). In order to reduce the
ADHD public health burden, there is a critical need to
further understand the complex origins of ADHD and early
etiological pathways to neurodevelopmental vulnerability.
Comprehensive theories of ADHD (Nigg 2005;
Sonuga-Barke 2002) focus on multiple neurodevelopmen-
tal pathways to ADHD and provide a framework to con-
ceptualize phenotypic heterogeneity within ADHD.
Multiple genetic and prenatal environmental risk factors
for ADHD have been identified; however, it is unclear how
genetic and environmental risk factors coalesce to alter
ADHD risk. Researchers have begun to examine how
genetic pathways may impact molecular and cellular pro-
cesses and ADHD risk (Poelmans et al. 2011; Yang et al.
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2013); however, there remains a significant need to
understand the role of prenatal environmental risk factors
in the etiology of ADHD (Nigg 2012).
Building on previous work linking prenatal hypoxia to
ADHD (Lou 1996; Toft 1999), this paper focuses on the
interplay between genetic, epigenetic, and environmental
risk to examine molecular pathways to ADHD, with a
specific focus on the ischemia-hypoxia response pathway.
To this end, we first briefly review empirical evidence and
theory implicating prenatal ischemia-hypoxia (e.g.,
preeclampsia) and perinatal ischemia-hypoxia (e.g., birth
asphyxia) in the development of ADHD and other neu-
rodevelopmental disorders. Next, we focus on the potential
role of genetic and epigenetic variation in genes shown to
be involved in the ischemia-hypoxia response. Last, we
review the similarities between neurodevelopmental
sequelae of ischemia-hypoxia and neurodevelopmental
correlates of ADHD. We conclude by discussing important
methodological issues in this domain and suggestions for
future research. The goal of the proposed model is to
partially account for etiological heterogeneity in ADHD by
articulating a putative developmental pathway from pre-
and perinatal ischemia-hypoxia to ADHD risk.
Lower birth weight and ADHD risk: Pre-
and perinatal ischemia-hypoxia as a shared
determinant
Birth weight and ADHD risk
Lower birth weight is associated with a wide-range of
chronic health and behavioral conditions (Boulet et al.
2011; Gluckman and Hanson 2004) and is one of the
strongest, and most studied, risk factors for ADHD (Nigg
et al. 2010; Thapar et al. 2013). There is a dose–response
relationship between lower birth weight and ADHD risk
that is continuous in nature (Boulet et al. 2011; Phua et al.
2012; van Os et al. 2001). In addition, birth weight is
associated with increased risk for ADHD over and above
gestational age (Lahti et al. 2006). When examined cate-
gorically, low birth weight (\2500 g) is associated with an
approximately two to threefold increase in ADHD risk
(Breslau et al. 1996; Linnet et al. 2006; Mick et al. 2002)
after adjusting for covariates including child sex, SES,
maternal stress, parental psychopathology, substance
abuse, and maternal smoking (Breslau et al. 1996; Elgen
et al. 2003; Horwood et al. 1998; Indredavik et al. 2004;
Linnet et al. 2006; Zubrick et al. 2000). Further, sibling
comparison (Class et al. 2014) and discordant twin studies
(Ficks et al. 2013; Groen-Blukhuis et al. 2011; Hultman
et al. 2007) indicate that the relationship between birth
weight and ADHD is not accounted for by genetic factors
alone. Despite the well-established association between
lower birth weight and ADHD, there is a paucity of
research examining etiological pathways that both limit
fetal growth and increase ADHD risk.
Prenatal ischemia-hypoxia, birth weight, and ADHD
risk
The relationship between lower birth weight and ADHD is
likely driven by precipitating environmental and genetic
factors. Prenatal ischemia-hypoxia, or an insufficient sup-
ply of nutrients and oxygen to the developing fetus, is a
primary pathway to lower birth weight (Henriksen and
Clausen 2002; Kinzler and Vintzileos 2008) and prematu-
rity (Salmaso et al. 2014). Prenatal ischemia-hypoxia is
implicated in a range of neurodevelopmental disorders,
including ADHD (Getahun et al. 2013; Owens and Hin-
shaw 2013), autism (Gardener et al. 2009; Kolevzon et al.
2007), schizophrenia (Mittal et al. 2008; Schmidt-Kastner
et al. 2012; Schmidt-Kastner et al. 2006), and cerebral
palsy (Derrick et al. 2007; Mwaniki et al. 2012). In par-
ticular, obstetric complications associated with reduced
nutrient and oxygen supply during the prenatal period (e.g.,
preeclampsia) or perinatal period (e.g., birth asphyxia)
increase risk for ADHD (Getahun et al. 2013; Pineda et al.
2007) and ADHD-related comorbidity (Owens and Hin-
shaw 2013). Furthermore, multiple prenatal environmental
risk factors for ADHD (Froehlich et al. 2011), such as
maternal smoking (Bush et al. 2000; Knopik 2009, 2010;
Knopik et al. 2005, 2012, 2015, 2016) and maternal alcohol
use (Bosco and Diaz 2012; Knopik et al. 2006) also lead to
restricted fetal growth, partially through prenatal ischemia-
hypoxia (Table 1). Genetically informed studies, however,
demonstrate that the relationship between prenatal envi-
ronmental risk factors, birth weight and ADHD is complex,
and are at least partially accounted for by genetic factors
(e.g., Thapar et al. 2009; Knopik et al. 2005, 2015, 2016).
Taken together, ischemia-hypoxia during pregnancy and
delivery results from a range of obstetric conditions and
fetal exposures, which limit fetal growth, and may account
for a substantial portion of the ADHD disease burden
(Fig. 1).
Ischemia-hypoxia response (IHR)
In response to prenatal ischemia-hypoxia, the placental-
fetal unit initiates a cascade of responses to preferentially
allocate oxygen and nutrients to promote survival (Murray
2012). Exposure to ischemia-hypoxia leads to changes in
metabolic demand (Murray 2012; Wheaton and Chandel
2011), angiogenesis (Shibuya 2008), inflammatory/im-
mune response (Ellison et al. 2005), neuroprotective/neu-
rotoxic systems (Myint et al. 2007), oxidative stress
(Prabakaran et al. 2004), and blood flow redistribution
(Roza et al. 2008). Importantly, all of these processes are
also implicated in the etiology of ADHD (Lesch et al.
2013; Lou 1996; Lou et al. 2004; Oades 2011; Oades et al.
2010; Ribases et al. 2008; Roza et al. 2008; Sanchez-Mora
et al. 2010; Todd and Botteron 2001). Collectively, the
ischemia-hypoxia response (IHR) may function to mini-
mize damage to neural tissue from an ischemic-hypoxic
pre- and perinatal environment.
Neurodevelopmental outcomes following ischemia-hy-
poxia exposure, however, are highly variable. Therefore, it
is critical to identify genetic and epigenetic factors that
might moderate or mediate the association between
ischemia-hypoxia and ADHD. Most previous gene by
environment interaction (GxE) studies in ADHD selected
candidate genes that have shown an association with the
disorder (see Nigg et al. 2010; for a review). This approach
has a limited conceptual basis and may be related to the
inconsistent findings in the ADHD GxE literature (Ficks
and Waldman 2009). In contrast, candidate genes or
pathways should be selected based on converging evidence
from multiple sources (Dick et al. 2015), including their
functional significance in relation to the putative environ-
mental pathogen (Moffitt et al. 2005)—in this case, pre-and
perinatal ischemia-hypoxia. We have shown that SNPs in
angiogenic (NRP1 & NRP2), neurotrophic (NTRK1 &
NTRK3), and inflammatory genes (CCBL1, CCBL2, IL16,
S100B) moderate the association between birth weight
centile and ADHD symptom severity (Smith et al. 2014).
These genetic systems have been implicated in the ische-
mia-hypoxia response and analyses in BrainCloud
(Colantuoni et al. 2011) suggest many of these genes are
expressed in the prefrontal cortex at relatively higher
levels during prenatal development compared to later
Table 1 Population
attributable fractions (PAF) for
ischemia-hypoxia related pre-
and perinatal environmental risk
factors and ADHD
Risk factor Adj. RR estimate PAF estimate (%)
Low birth weight (\2500 g) 2.85a 12.8b
Maternal smoking 1.53c 7.0b
Maternal alcohol use/non-FAS spec 5.00b 2.4b
Adj. OR estimate PAF estimate (%)
Preeclampsia 1.34d 2.5d
Prolapsed/nuchal cord 1.13d 2.0d
Placental abruption 1.16d 0.2d
Breech/transverse presentation 1.13d 0.7d
Respiratory distress syndrome 1.47d 0.6d
Neonatal resuscitation 2.75d 0.4d
Apgar score of\7 at 5 min 1.31d 0.3d
Fetal dystocia 1.11d 0.2d
Adj RR adjusted relative risk, Adj OR adjusted odds ratio, PAF population attributable fraction—the
percentage of ADHD cases attributed to a given risk factor. Relative risk and odds ratio estimates are
derived from single studies and may overestimate the true association between a risk factor and ADHD;
however, attempts were made to limit such biases (see Nigg 2006, pp. 226–241; Getahun et al. 2013)
a Breslau et al. 1996
b Nigg 2006
c Linnet et al. 2003









Fig. 1 Prenatal ischemia-hypoxia and the ischemia-hypoxia response
are predicted to underlie the association between lower birth weight
and ADHD. This model depicts how chronic prenatal ischemia-
hypoxia partially determines the association between lower birth
weight and attention-deficit/hyperactivity disorder (ADHD) risk.
Acute pre- or perinatal ischemia-hypoxia (e.g., umbilical cord
prolapse) may still contribute to ADHD risk; however, birth weight
may not be affected. IHR ischemia hypoxia-response
development (See Supplementary Fig. 1). This provides
preliminary evidence that developmental systems involved
in the ischemia-hypoxia response are associated with
ADHD risk and effects likely depend on prenatal envi-
ronmental influences.
Additionally, bioinformatic tools (Viswanathan et al.
2008) can assist in the identification of specific genes and
genetic pathways that are implicated in the IHR. Of partic-
ular interest are genes that are functionally related to hypoxia
inducible factor 1 or 2 (HIF-1; HIF-2), which regulate the
cellular response to hypoxia and are expressed in the brain.
HIFs promote adaptation to hypoxic conditions by regulating
the transcription of IHR genes (Sharp and Bernaudin 2004),
which confer neurological and vascular adaptation (Sch-
midt-Kastner et al. 2006; Schmidt-Kastner et al. 2012; Sharp
and Bernaudin 2004). HIF-1 is necessary for normal
embryonic (Yu et al. 1999), neural, and vascular develop-
ment (Tomita et al. 2003). In addition, the vascular
endothelial growth factor family is the main regulator of
angiogenesis (i.e., the formation of new blood vessels; Shi-
buya 2008; Shibuya and Claesson-Welsh 2006). The
angiogenic system is implicated in ADHD etiology (Jesmin
et al. 2004; Smith et al. 2014) and is upregulated in response
to hypoxia, a process that ismediated byHIFs (MacGabhann
and Popel 2008) and epigenetic mechanisms (Mimura et al.
2012; Skowronski et al. 2010). Although the IHR aims to
protect neural tissue from ischemia-hypoxia, IHR effects
may persist and alter susceptibility for neurodevelopmental
disorders later in life.
Developmental origins of ADHD: Epigenetic
programming and neurodevelopmental risk
The Developmental Origins of Health and Disease
hypothesis (DOHaD; Gluckman and Hanson 2004; Mill
and Petronis 2008; Nigg 2012; Swanson and Wadhwa
2008) builds on the theory of ‘‘fetal programming’’ (Barker
2007) and provides an integrative framework to concep-
tualize the interplay between environmental, genetic and
epigenetic factors in determining birth and health out-
comes. Briefly, DOHaD posits that the prenatal environ-
mental influences are associated with birth outcomes. This
association is presumed to be mediated by epigenetic
changes which allow the developing fetus to adapt the
structure and function of developmental systems to pro-
mote survival. Additionally, prenatal environmental influ-
ences may disrupt or constrain developmental plasticity
(see Gluckman and Hanson 2004). To the extent that there
is a mismatch between the prenatal and postnatal envi-
ronments the individual may be ill-quipped to function
adaptively in the postnatal environment. This mismatch
confers vulnerability for later disease as the organism is
functioning in an environment for which it was not epi-
genetically programmed to be adaptive in.
From a DOHaD perspective, the association between
lower birth weight and ADHD may arise from a milieu of
obstetric complications which lead to pre- and perinatal
ischemia hypoxia. The placental-fetal unit will adapt to the
ischemic-hypoxic environment by altering the structure
and function of developmental systems, including the
brain. Further, prenatal ischemia-hypoxia may lead to
neural disruption (e.g., intraventricular hemorrhage; Whi-
taker et al. 2011) or place constraints on neurodevelop-
mental processes (e.g., cerebral blood flow; Fu and
Olofsson 2011). At the molecular level, the IHR response
functions to promote survival in the context of cerebral
ischemia-hypoxia. Consistent with DOHaD, however, the
IHR response may leave ADHD-related brain regions ill-
equipped to function in a nutrient and oxygen rich postnatal
environment, increasing ADHD risk later in life. IHR
genetic variability and ischemia-hypoxia induced epige-
netic changes (described below) may confer increased risk
or protection from ADHD, following pre- and perinatal
environmental risk exposure (Mill and Petronis 2008).
Ischemia-hypoxia induced epigenetic effects
Epigenetic mechanisms are a primary mechanism linking
adverse intrauterine environments with later risk for dis-
ease (Wadhwa et al. 2009). Epigenetic changes in DNA
methylation, histone modifications, and noncoding RNA
have been shown, in part, to be induced by exposure to
prenatal ischemia-hypoxia and alter gene expression
(Watson et al. 2010). Ischemia-hypoxia induced epigenetic
alterations are maintained in the absence of HIFs (Tsai and
Wu 2013; Watson et al. 2010), suggesting they may con-
tinue to impact behavioral phenotypes later in life. DNA
methylation, for example, is the addition of a methyl group
to a cytosine in cytosine/guanine-rich DNA regions
(Maccani and Marsit 2009). When cytosines in the gene’s
promoter region are methylated, gene expression is gen-
erally reduced or silenced. Of note, lasting changes in
global DNA methylation are observed in the rat brain
following cerebral ischemia-hypoxia (Wu et al. 2013).
Taken together, decreased nutrient and oxygen availability
in utero may alter IHR gene expression (Schmidt-Kastner
et al. 2012), through HIFs and epigenetic mechanisms,
leading to altered susceptibility for ADHD and related
outcomes (Wang et al. 2013).
Pre- and perinatal ischemia-hypoxia
and neurodevelopmental risk
Pre- and perinatal ischemia-hypoxia leads to lasting chan-
ges in neurodevelopmental functioning, especially in males
(Mueller and Bale 2008). This phenomenon may partially
account for ADHD male preponderance (Jesmin et al.
2004; Laplante et al. 2012) and persistence overtime. Thus,
it is critical to understand neurodevelopmental sequelae of
prenatal ischemia-hypoxia and their relation to ADHD
vulnerability. We briefly address four areas we believe to
be of neurodevelopmental importance below: (i) neu-
roanatomical alterations, (ii) neurotransmission perturba-
tion, (iii) neuroinflammation, and (iv) cerebral vascular
response.
Neuroanatomical alterations
In animal models, chronic pre- and perinatal ischemia-
hypoxia is associated with reductions in brain weight,
myelination, neurogenesis, synaptogenesis, and white
matter damage (Bassan et al. 2010; Mallard et al. 1999), as
well as delays in interneuron, astroglia, and oligoden-
droglia maturation (Salmaso et al. 2014). Generally, these
findings persist into adulthood (Rehn et al. 2004).
Numerous human studies highlight the association between
fetal growth restriction (an indicator of pre- and perinatal
ischemia-hypoxia) and neuroanatomical and neurocogni-
tive outcomes. For instance, in a population-based study,
lower birth weight predicted decreased anterior cingulate,
caudate and total brain volume in childhood (Walhovd
et al. 2012). Additionally, growth-restricted infants have
reductions in overall white and gray matter compared to
infants in the normal birth weight range (Brown et al. 2009;
Larroque et al. 2003; Tolsa et al. 2004). These neu-
roanatomical findings relate to poor performance on mea-
sures of inattention and impulsivity (Peterson et al. 2003;
Tolsa et al. 2004) and are consistent with neurocognitive
findings in ADHD samples (Filipek et al. 1997; Kates et al.
2002; Mostofsky et al. 2002; Overmeyer et al. 2001).
Furthermore, within a low birth weight cohort, immature
white matter lesions and ventricular enlargement, which
are suggestive of ischemia-hypoxia exposure, predicted
increased risk for ADHD (Whitaker et al. 1997, 2011).
Taken together, neurodevelopmental outcomes in pre- and
perinatal ischemia-hypoxia animal models and human
studies suggest neurodevelopmental delays or disruptions,
which are functionally related to ADHD symptomatology.
Neurotransmisssion perturbation
Dopaminergic dysfunction remains of central interest for
the pathophysiology and genetics of ADHD (Biederman
and Faraone 2005; Castellanos and Tannock 2002; Swan-
son et al. 2007). The role of dopaminergic neurons, fibers,
and synapses has been studied in animal models of pre- and
perinatal ischemia-hypoxia (Boksa and El-Khodor 2003).
Loss of dopaminergic neurons has not been observed in
perinatal models, but dysfunction such as imbalances in
dopamine release and abnormal receptor expression have
been reported (Boksa and El-Khodor 2003; Chen et al.
1997; Ungethum et al. 1996). Bjelke et al. (1991) described
increased numbers of tyrosine-hydroxylase positive,
dopaminergic neurons in the substantia nigra in a perinatal
anoxia model. The transcription factor HIF-1 has been
related to the development of nigral dopamine neurons
(Milosevic et al. 2007) and to dopamine toxicity (Lee et al.
2009). Interestingly, dopaminergic neurons of the mouse
substantia nigra and ventral tegmental area express mainly
ARNT as HIF-1 beta subunit and only low levels of
ARNT2, contrasting with dual expression in cortical and
hippocampal neuronal populations (Dela Cruz et al. 2014).
We have speculated that this expression pattern may limit
the reaction of midbrain dopaminergic neurons to hypoxia
(Dela Cruz et al. 2014). In adult rats, lesions can be
observed in the substantia nigra pars reticulata under severe
ischemic conditions whereas the dopaminergic nigral
neurons are resistant (Inamura et al. 1987). The human
striatum is vulnerable to perinatal ischemia-hypoxia (Lou
et al. 2004), and experimental studies show dysmaturation
of striatal projection neurons following pre-natal hypoxia
(McClendon et al. 2014). The interaction between early
striatal damage and dysfunction of the dopaminergic input
remains to be understood. One intriguing hypothesis (Toft
1999) is that subtle damage to frontostriatal circuitry would
lead to specific deficits in sustained attention and response
inhibition underlying ADHD behavioral symptoms and
related functional deficits (Gau et al. 2015). Taken toge-
ther, experimental evidence indicates that pre- and peri-
natal hypoxia can have lasting effects on the dopaminergic
function, whereas neuronal death does not seem to play a
role.
ADHD is also associated with altered glutamatergic
transmission (Elia et al. 2012; Lesch et al. 2013). In con-
trast to findings related to dopaminergic functioning, pre-
natal ischemia-hypoxia leads to energy depletion in the
fetal brain and neuronal apoptosis (cell death) from gluta-
mate-induced excitotoxicity (Back and Rosenberg 2014).
Interestingly, neuronal energy deficiency has also been
proposed as a biological underpinning of ADHD (Todd and
Botteron 2001).
Neuroinflammation
In response to prenatal ischemia-hypoxia and neuronal
apoptosis, the immune system responds by increasing cir-
culating pro-inflammatory cytokines, which further com-
promises fetal brain development (Jellema et al. 2013).
Pro-inflammatory cytokines may lead to increased blood–
brain barrier permeability (Kaur and Ling 2008) and
excessive quinolinic acid, a glutamate receptor agonist,
which at heightened levels is neurotoxic (Myint et al.
2007). Indeed, elevated levels of circulating cytokines in
perinatal development are associated with multiple neu-
rodevelopmental deficits (e.g., Krakowiak et al. 2015),
including ADHD diagnosis (Oades 2011) and ADHD
neurocognitive endophenotypes (Oades et al. 2010).
Cerebral vascular response
Doppler velocimetry studies have shown that, in response
to fetal hypoxia, the fetus increases distribution of blood
flow to the brain (Fu and Olofsson 2006). Though this
‘‘brain-sparing flow’’ may confer survival advantage in the
moment, it is associated with decreased vascular plasticity
in the future (Fu and Olofsson 2006) and increased risk for
ADHD symptoms at 3 years of age (Roza et al. 2008).
Thus, fetal adaptations to prenatal ischemia-hypoxia and
aberrant vascular adaptations may lead to increased vul-
nerability for later neurodevelopmental and behavioral
problems.
Summary and research considerations
Converging lines of evidence indicate that ischemia-hy-
poxia is an early environmental pathogen for ADHD and
related neurodevelopmental outcomes. Ischemia-hypoxia is
a common element of multiple (often viewed as disparate)
prenatal environmental risk factors, including low birth
weight, prematurity, various obstetric complications, and
maternal smoking during pregnancy (Table 1). To promote
the identification of etiological pathways to ADHD, it is
important to consider the physiological sequelae of pre-
natal environmental risk factors. From this perspective,
prenatal ischemia-hypoxia may initiate one common early
etiological pathway to ADHD. Further, the IHR pathway
highlights regions of the genome and epigenome that are
particularly relevant to the development of ADHD, espe-
cially in the context of prenatal environmental risk. Fur-
ther, preliminary evidence suggests that prenatal ischemia-
hypoxia may help to explain male preponderance of
ADHD (Jesmin et al. 2004; Laplante et al. 2012) as well as
phenotypic heterogeneity in ADHD symptomatology (Toft
1999; Gau et al. 2015), persistence (e.g., Wu et al. 2013)
and comorbidity (Owens and Hinshaw 2013).To better
elucidate mechanisms linking pre- and perinatal ischemia-
hypoxia and ADHD, consideration should be given to the
following methodological issues.
First, there is little consensus on the most appropriate
indicators of pre- and perinatal ischemia-hypoxia. Low
birth weight is often utilized as a general proxy for an
adverse intrauterine environment. Low birth weight, how-
ever, is multifactorial and may identify individuals who are
either constitutionally small or premature, but not growth
restricted (Maulik 2006) and not exposed to prenatal
ischemia-hypoxia. Appropriately grown individuals that
are born premature do not appear to be at increased risk for
ADHD (Heinonen et al. 2010). Therefore, in models of
ADHD risk, it is more appropriate to utilize measures of
fetal growth that adjust for gestational age as well as other
covariates (e.g., sex, parity, and ancestry), such as cus-
tomized birth centiles. Customized birth centiles may bet-
ter capture vulnerability for ADHD due to limited nutrient
and oxygen supply in utero compared to birth weight alone
as they provide better estimates of growth potential. This
measurement approach, however, is not proximally related
to prenatal ischemia-hypoxia, prompting the need for more
direct measures of prenatal ischemia-hypoxia in human
studies, such as Doppler ultrasound assessment of fetal
cerebral blood flow (e.g., Roza et al. 2008).
Ischemia-hypoxia related obstetric complications during
pregnancy and birth (see Table 1) may provide a more
accurate measure of ischemia-hypoxia exposure. Creating a
weighted summary score of chronic and acute pre- and
perinatal risk factors allows for ischemia-hypoxia exposure
severity to be measured on a continuum (Getahun et al.
2013; Lewis and Murray 1987). In addition, directly
measuring maternal-placental-fetal blood flow with Dop-
pler ultrasound may provide a more direct measure of
prenatal ischemia (Guvendag et al. 2013; Thuring et al.
2012) at the time of assessment. Further, placental
pathology examination may provide researchers a physio-
logical measure of limited placental-fetal blood and oxygen
flow, which have previously been linked to autism (Walker
et al. 2013). Direct measures of prenatal ischemia-hypoxia
in human studies are sorely needed to increase the public
health impact of research in this domain.
Second, evidence from microarray gene expression
studies in brain tissue of mice implicates a wide-range of
genes in the ischemia-hypoxia response, which may play
an important role in ADHD etiology, especially following
an adverse intrauterine environment. Therefore, a multi-
omic approach is required to examine the interplay
between prenatal environmental risk, genomic, epige-
nomic, and transcriptomic factors. This would involve
integrating genomic, epigenomic and transcriptomic data
within the IHR pathway. Analytical approaches for inte-
grating multi-omic data are still in the early stages of
development (Lasky-Su 2013). In addition, it is unclear
how well epigenetic alternations and gene expression in the
brain relate to levels in peripheral tissues (e.g., blood),
which are accessible in human studies (Day et al. 2013;
Tylee et al. 2013). Studies examining tissue specificity and
temporal stability of IHR epigenetic and expression chan-
ges in response to ischemia-hypoxia are needed. Leverag-
ing developmental gene expression databases (e.g., Allen
Brain Atlas; BrainCloud; BRAINSPAN) will help to target
genes that are relevant to prenatal brain development.
Third, to complement epidemiological studies, there is
critical need to leverage experimental and quasi-experi-
mental designs in animals and humans, respectively.
Experimental methods which leverage inbred strains of
rodents provide the critical methodological control for
genetic differences that otherwise obfuscate environmen-
tally-induced epigenetic and expression differences in the
IHR pathway. Genetically-informed human studies (e.g.,
co-twin, sibling comparisons, and children-of-twin) may
help to further isolate causal prenatal environmental factors
for ADHD and related neurodevelopmental disorders.
Thus, utilizing epidemiological and experimental research
methods in this domain will help to both identify specific
pre- and perinatal environmental causes and molecular
mechanisms linking prenatal ischemia-hypoxia exposure
with ADHD risk.
In conclusion, prenatal ischemia-hypoxia and IHR genes
and epigenetic mechanisms may initiate one, among many,
possible developmental cascades that ultimately increases
risk for ADHD and related neurodevelopmental outcomes.
Multi-omic research linking prenatal ischemia-hypoxia
with lasting neurodevelopmental vulnerability is needed to
better elucidate the role of the IHR pathway in ADHD
vulnerability. Such research may help to identify molecular
mechanisms associated with neurodevelopmental risk/pro-
tection following exposure to an adverse pre- and perinatal
environment. Ultimately, this research may inform pre-
ventative interventions for ADHD targeting individuals
exposed to pre- and perinatal ischemia-hypoxia.
Acknowledgments Authors were supported by the following
sources: T32MH19927 and RSCA award California Polytechnic State
University (Smith) and DA023134 (Knopik). The content of this
article is solely the responsibility of the authors and does not neces-
sarily represent the official views of the Department of Veteran
Affairs.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflict
of interest.
Human and Animal Rights and Informed Consent This review
article does not contain any studies with human or animal subjects
performed by any of the authors.
References
American Psychiatric Association (2013) Diagnostic and statistical
manual of mental disorders: DSM-5. Am Psychiatr Assoc,
Arlington
Angold A, Costello EJ, Erkanli A (1999) Comorbidity. J Child
Psychol Psychiatry 40(1):57–87
Back S, Rosenberg P (2014) Pathophysiology of glia in perinatal
white matter injury. Glia 62(11):1790
Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Killian JM,
Katusic SK (2013) Mortality, ADHD, and psychosocial adversity
in adults with childhood ADHD: a prospective study. Pediatrics
131(4):637–644
Barker DJP (2007) The origins of the developmental origins theory.
J Intern Med 261(5):412–417
Bassan H, Kidron D, Bassan M, Rotstein M, Kariv N, Giladi E,
Davidson A, Gozes I, Harel S (2010) The effects of vascular
intrauterine growth retardation on cortical astrocytes. J Matern
Fetal Neonatal Med 23(7):595–600
Biederman J, Faraone SV (2005) Attention-deficit hyperactivity
disorder. Lancet 366(9481):237–248
Bjelke B, Andersson K, Ogren SO, Bolme P (1991) Asphyctic lesion:
proliferation of tyrosine hydroxylase-immunoreactive nerve cell
bodies in the rat substantia nigra and functional changes in
dopamine neurotransmission. Brain Res 543(1):1–9
Boksa P, El-Khodor BF (2003) Birth insult interacts with stress at
adulthood to alter dopaminergic function in animal models:
possible implications for schizophrenia and other disorders.
Neurosci Biobehav Rev 27(1–2):91–101
Bosco C, Diaz E (2012) Placental hypoxia and foetal development
versus alcohol exposure in pregnancy. Alcohol Alcohol
47(2):109–117
Boulet SL, Schieve LA, Boyle CA (2011) Birth weight and health and
developmental outcomes in US children, 1997–2005. Matern
Child Health J 15(7):836–844
Breslau N, Brown G, DelDotto J, Kumar S, Ezhuthachan S, Andreski
P, Hufnagle K (1996) Psychiatric sequelae of low birth weight at
6 years of age. J Abnorm Child Psychol 24(3):385–400
Brown N, Inder T, Bear M, Hunt R, Anderson P, Doyle L (2009)
Neurobehavior at term and white and gray matter abnormalities
in very preterm infants. J Pediatr 155(1):32–38
Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD, Page
KR (2000) Maternal cigarette smoking and oxygen diffusion
across the placenta. Placenta 21(8):824–833
Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit/
hyperactivity disorder: the search for endophenotypes. Nat Rev
Neurosci 3(8):617–628
Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B,
Gross J, Andersson K, von Euler G (1997) Perinatal asphyxia
induces long-term changes in dopamine D1, D2, and D3 receptor
binding in the rat brain. Exp Neurol 146(1):74–80
Class QA, Rickert ME, Larsson H, Lichtenstein P, D’Onofrio BM
(2014) Fetal growth and psychiatric and socioeconomic prob-
lems: population-based sibling comparison. Br J Psychiatry
205(5):355–361
Colantuoni C, Lipska BK, Ye TZ, Hyde TM, Tao R, Leek JT,
Colantuoni EA, Elkahloun AG, Herman MM, Weinberger DR,
Kleinman JE (2011) Temporal dynamics and genetic control of
transcription in the human prefrontal cortex. Nature
478:519–524
Day K, Waite L, Thalacker-Mercer A, West A, Bamman M, Brooks J,
Myers R, Absher D (2013) Differential DNA methylation with
age displays both common and dynamic features across human
tissues that are influenced by CpG landscape. Genome Biol
14(9):R102
Dela Cruz JA, Schmidt-Kastner R, Stevens JA, Steinbusch HW,
Rutten BP (2014) Differential distribution of hypoxia-inducible
factor 1-beta (ARNT or ARNT2) in mouse substantia nigra and
ventral tegmental area. J Chem Neuroanat 61–62:64–71
Derrick M, Drobyshevsky A, Ji X, Tan S (2007) A model of cerebral
palsy from fetal hypoxia-ischemia. Stroke 38(2 Suppl):731–735
Dick DM, Agrawal A, Keller MC, Adkins A, Aliev F, Monroe S,
Hewitt JK, Kendler KS, Sher KJ (2015) Candidate gene-
environment interaction research: reflections and recommenda-
tions. Perspect Psychol Sci 10(1):37–59
Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan
J, Erder MH, Neumann PJ (2012) Economic impact of childhood
and adult attention-deficit/hyperactivity disorder in the United
States. J Am Acad Child Adolesc Psychiatry 51(10):990–1002
Elgen I, Sommerfelt K, Markestad T (2003) Population based,
controlled study of behavioural problems and psychiatric
disorders in low birthweight children at 11 years of age. Obstet
Gynecol Surv 58(2):103
Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D,
Sleiman PM, Zhang H, Kim CE, Robison R (2012) Genome-
wide copy number variation study associates metabotropic
glutamate receptor gene networks with attention deficit hyper-
activity disorder. Nat Genet 44(1):78–84
Ellison VJ, Mocatta TJ, Winterbourn CC, Darlow BA, Volpe JJ, Inder
TE (2005) The relationship of CSF and plasma cytokine levels to
cerebral white matter injury in the premature newborn. Pediatr
Res 57(2):282–286
Ficks CA, Waldman ID (2009) Gene-environment interactions in
attention-deficit/hyperactivity disorder. Curr Psychiatry Rep
11(5):387–392
Ficks C, Lahey B, Waldman I (2013) Does low birth weight share
common genetic or environmental risk with childhood disruptive
disorders? J Abnorm Psychol 122(3):842–853
Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF,
Kennedy DN, Biederman J (1997) Volumetric MRI analysis
comparing subjects having attention-deficit hyperactivity disor-
der with normal controls. Neurology 48(3):589–601
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L,
Gilman RC (2011) Update on environmental risk factors for
attention-deficit/hyperactivity disorder. Curr Psychiatry Rep
13(5):333–344
Fu J, Olofsson P (2006) Restrained cerebral hyperperfusion in
response to superimposed acute hypoxemia in growth-restricted
human fetuses with established brain-sparing blood flow. Early
Hum Dev 82(3):211–216
Fu J, Olofsson P (2011) Relations between fetal brain-sparing
circulation, oxytocin challenge test, mode of delivery and fetal
outcome in growth-restricted term fetuses. Acta Obstet Gyn Scan
90(3):227–230
Gardener H, Spiegelman D, Buka SL (2009) Prenatal risk factors for
autism: comprehensive meta-analysis. Br J Psychiatry
195(1):7–14
Gau SS, Tseng WL, Tseng WY, Wu YH, Lo YC (2015) Association
between microstructural integrity of frontostriatal tracts and
school functioning: ADHD symptoms and executive function as
mediators. Psychol Med 45(3):529–543
Getahun D, Rhoads GG, Demissie K, Lu SE, Quinn VP, Fassett MJ,
Wing DA, Jacobsen SJ (2013) In utero exposure to ischemic-
hypoxic conditions and attention-deficit/hyperactivity disorder.
Pediatrics 131(1):e53–e61
Gluckman PD, Hanson MA (2004) Living with the past: evolution,
development, and patterns of disease. Science 305(5691):
1733–1736
Groen-Blukhuis MM, Middeldorp CM, van Beijsterveldt CE,
Boomsma DI (2011) Evidence for a causal association of low
birth weight and attention problems. J Am Acad Child Adolesc
Psychiatry 50(12):1247–1254
Guvendag GE, Karcaaltincaba D, Kandemir O, Kiykac S, Mentese A
(2013) Cord blood oxidative stress markers correlate with
umbilical artery pulsatility in fetal growth restriction. J Matern
Fetal Neonatal Med 26(6):576
Heinonen K, Ra¨ikko¨nen K, Pesonen A-K, Andersson S, Kajantie E,
Eriksson JG, Wolke D, Lano A (2010) Behavioural symptoms of
attention deficit/hyperactivity disorder in preterm and term
children born small and appropriate for gestational age: a
longitudinal study. BMC Pediatr 10:91
Henriksen T, Clausen T (2002) The fetal origins hypothesis: placental
insufficiency and inheritance versusmaternalmalnutrition inwell-
nourished populations. Acta Obstet Gyn Scan 81(2):112–114
Horwood L, Mogridge N, Darlow B (1998) Cognitive, educational,
and behavioural outcomes at 7 to 8 years in a national very low
birthweight cohort. Arch Dis Child Fetal Neonatal Ed 79(1):F12
Hultman CM, Torra˚ng A, Tuvblad C, Cnattingius S, Larsson JO,
Lichtensetin P (2007) Birth weight and attention-deficit/hyper-
activity symptoms in childhood and ealry adolescence: a
prospective Swedish twin study. J Am Acad Child Adolesc
Psychiatry 46(3):370–377
Inamura K, Olsson Y, Siesjo BK (1987) Substantia nigra damage
induced by ischemia in hyperglycemic rats. A light and electron
microscopic study. Acta Neuropathol 75(2):131–139
Indredavik M, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk A
(2004) Psychiatric symptoms and disorders in adolescents with
low birth weight. Arch Dis Child Fetal Neonatal Ed 89(5):F445
Jellema R, Lima PV, Zwanenburg A, Ophelders D, De Munter S,
Vanderlocht J, Germeraad W, Kuypers E, Collins J, Cleutjens J
(2013) Cerebral inflammation and mobilization of the peripheral
immune system following global hypoxia-ischemia in preterm
sheep. J Neuroinflamm 10:13
Jesmin S, Togashi H, Mowa CN, Ueno K, Yamaguchi T, Shibayama
A, Miyauchi T, Sakuma I, Yoshioka M (2004) Characterization
of regional cerebral blood flow and expression of angiogenic
growth factors in the frontal cortex of juvenile male SHRSP and
SHR. Brain Res 2:172–182
Kates WR, Frederikse M, Mostofsky SH, Folley BS, Cooper K,
Mazur-Hopkins P, Kofman O, Singer HS, Denckla MB, Pearlson
GD, Kaufmann WE (2002) MRI parcellation of the frontal lobe
in boys with attention deficit hyperactivity disorder or Tourette
syndrome. Psychiatry Res 116(1–2):63–81
Kaur C, Ling E (2008) Blood brain barrier in hypoxic-ischemic
conditions. Curr Neurovasc Res 5(1):71
Kinzler W, Vintzileos A (2008) Fetal growth restriction: a modern
approach. Curr Opin Obstet Gynecol 20(2):125
Knopik VS (2009) Maternal smoking during pregnancy and child
outcomes: real or spurious effect? Dev Neuropsychol 34(1):1–36
Knopik VS (2010) Commentary: smoking during pregnancy—genes
and environment weigh in. Int J Epidemiol 39(5):1203–1205
Knopik VS, Sparrow EP, Madden PA, Bucholz KK, Hudziak JJ, Reich
W, Slutske WS, Grant JD, McLaughlin TL, Todoro A, Todd RD,
Heath AC (2005) Contributions of parental alcoholism, prenatal
substance exposure, and genetic transmission to child ADHD risk:
a female twin study. Psychol Med 35(5):625-635
Knopik VS, Heath AC, Jacob T, Slutske WS, Bucholz KK, Madden
PA, Waldron M, Martin NG (2006) Maternal alcohol use
disorder and offspring ADHD: disentangling genetic and envi-
ronmental effects using a children-of-twins design. Psychol Med
36(10):1461–1471
Knopik VS, Maccani MA, Francazio S, McGeary JE (2012) The
epigenetics of maternal cigarette smoking during pregnancy and
effects on child development. Dev Psychopathol 24(4):1377–1390
Knopik VS, Marceau K, Palmer RHC, Smith TF, Heath AC (2015)
Maternal smoking during pregnancy and offspring birth weight:
A genetically-informed approach incorporating multiple raters.
Behav Genet. doi:10.1007/s10519-015-9750-6
Knopik VS, Marceau K, Bidwell LC, Palmer RHC, Smith TF, Todorov
A, Evans AS, Heath AC (2016) Smoking during pregnancy and
ADHD risk: a genetically-informed, multiple-rater approach. Am
J Med Genet Part B. doi:10.1002/ajmg.b.32421
Kolevzon A, Gross R, Reichenberg A (2007) Prenatal and perinatal
risk factors for autism: a review and integration of findings. Arch
Pediatr Adolesc Med 161(4):326–333
Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Handen RL,
Hertz-Picciotto I, Van de Water J (2015) Neonatal cytokine
profiles associated with autism spectrum disorder. Biol Psychi-
atry. doi:10.1016/jbiopsych.2015.08.007
Lahti J, Raikkonen K, Kajantie E, Heinonen K, Pesonen AK,
Jarvenpaa AL, Strandberg T (2006) Small body size at birth and
behavioural symptoms of ADHD in children aged five to six
years. J Child Psychol Psychiatry 47(11):1167–1174
Laplante F, Brake WG, Chehab SL, Sullivan RM (2012) Sex
differences in the effects of perinatal anoxia on dopamine
function in rats. Neurosci Lett 506(1):89–93
Larroque B, Marret S, Ancel P, Arnaud C, Marpeau L, Supernant K,
Pierrat V, Roze´ J, Matis J, Cambonie G (2003) White matter
damage and intraventricular hemorrhage in very preterm infants:
the EPIPAGE study. J Pediatr 143(4):477–483
Lasky-Su J (2013) A network medicine approach to psychiatric
genetics. Am J Med Genet B Neuropsychiatr Genet 162(7):579
Lee DW, Rajagopalan S, Siddiq A, Gwiazda R, Yang L, Beal MF,
Ratan RR, Andersen JK (2009) Inhibition of prolyl hydroxylase
protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-
induced neurotoxicity: model for the potential involvement of
the hypoxia-inducible factor pathway in Parkinson disease.
J Biol Chem 284(42):29065–29076
LeschKP,Merker S, ReifA,NovakM (2013)Danceswith blackwidow
spiders: dysregulation of glutamate signalling enters centre stage
in ADHD. Eur Neuropsychopharmacol 23(6):479–491
Lewis S, Murray R (1987) Obstetric complications, neurodevelop-
mental deviance, and risk of schizophrenia. J Psychiatr Res
21(4):413
Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB,
Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J,
Jarvelin MR (2003) Maternal lifestyle factors in pregnancy risk
of attention deficit hyperactivity disorder and associated behav-
iors: review of the current evidence. Am J Psychiatry
160(6):1028–1040
Linnet K, Wisborg K, Agerbo E, Secher N, Thomsen P, Henriksen T
(2006) Gestational age, birth weight, and the risk of hyperkinetic
disorder. Arch Dis Child 91(8):655–660
Lou HC (1996) Etiology and pathogenesis of attention-deficit
hyperactivity disorder (ADHD): significance of prematurity
and perinatal hypoxic-haemodynamic encephalopathy. Acta
Paediatr 85(11):1266–1271
Lou HC, Rosa P, Pryds O, Karrebaek H, Lunding J, Cumming P,
Gjedde A (2004) ADHD: increased dopamine receptor avail-
ability linked to attention deficit and low neonatal cerebral blood
flow. Dev Med Child Neurol 46(3):179–183
Mac Gabhann F, Popel AS (2008) Systems biology of vascular
endothelial growth factors. Microcirculation 15(8):715–738
Maccani MA, Marsit CJ (2009) Epigenetics in the placenta. Am J
Reprod Immunol 62(2):78–89
Mallard E, Rehn A, Rees S, Tolcos M, Copolov D (1999)
Ventriculomegaly and reduced hippocampal volume following
intrauterine growth-restriction: implications for the aetiology of
schizophrenia. Schizophr Res 40(1):11–21
Maulik D (2006) Fetal growth compromise: definitions, standards,
and classification. Clin Obstet Gynecol 49(2):214–218
McClendon E, Chen K, Gong X, Sharifnia E, Hagen M, Cai V, Shaver
DC, Riddle A, Dean JM, Gunn AJ, Mohr C, Kaplan JS, Rossi DJ,
Kroenke CD, Hohimer AR, Back SA (2014) Prenatal cerebral
ischemia triggers dysmaturation of caudate projection neurons.
Ann Neurol 75(4):508–524
Mick E, Biederman J, Prince J, Fischer MJ, Faraone SV (2002)
Impact of low birth weight on attention-deficit hyperactivity
disorder. J Dev Behav Pediatr 23(1):16–22
Mill J, Petronis A (2008) Pre- and peri-natal environmental risks for
attention-deficit hyperactivity disorder (ADHD): the potential
role of epigenetic processes in mediating susceptibility. J Child
Psychol Psychiatry 49(10):1020–1030
Milosevic J, Maisel M, Wegner F, Leuchtenberger J, Wenger RH,
Gerlach M, Storch A, Schwarz J (2007) Lack of hypoxia-
inducible factor-1 alpha impairs midbrain neural precursor cells
involving vascular endothelial growth factor signaling. J Neu-
rosci 27(2):412–421
Mimura I, Nangaku M, Kanki Y, Tsutsumi S, Inoue T, Kohro T,
Yamamoto S, Fujita T, Shimamura T, Suehiro J, Taguchi A,
Kobayashi M, Tanimura K, Inagaki T, Tanaka T, Hamakubo T,
Sakai J, Aburatani H, Kodama T, Wada Y (2012) Dynamic
change of chromatin conformation in response to hypoxia
enhances the expression of GLUT3 (SLC2A3) by cooperative
interaction of hypoxia-inducible factor 1 and KDM3A. Mol Cell
Biol 32(15):3018–3032
Mittal VA, Ellman LM, Cannon TD (2008) Gene-environment
interaction and covariation in schizophrenia: the role of obstetric
complications. Schizophr Bull 34(6):1083–1094
Moffitt TE, Caspi A, Rutter M (2005) Strategy for investigating
interactions between measured genes and measured environ-
ments. Arch Gen Psychiatry 62(5):473–481
Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE
(2002) Smaller prefrontal and premotor volumes in boys with
attention-deficit/hyperactivity disorder. Biol Psychiatry
52(8):785–794
Mueller BR, Bale TL (2008) Sex-specific programming of offspring
emotionality after stress early in pregnancy. J Neurosci
28(36):9055–9065
Murray AJ (2012) Oxygen delivery and fetal-placental growth:
beyond a question of supply and demand? Placenta 33(Suppl
2):e16–e22
Mwaniki MK, Atieno M, Lawn JE, Newton CR (2012) Long-term
neurodevelopmental outcomes after intrauterine and neonatal
insults: a systematic review. Lancet 379(9814):445–452
Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B
(2007) Kynurenine pathway in major depression: evidence of
impaired neuroprotection. J Affect Disord 98(1–2):143–151
Nigg JT (2005) Neuropsychologic theory and findings in attention-
deficit/hyperactivity disorder: the state of the field and salient
challenges for the coming decade. Biol Psychiatry 57(11):
1424–1435
Nigg JT (2006) What causes ADHD? Understanding what goes wrong
and why. Guilford Press, New York
Nigg J (2012) Environment, developmental origins, and attention-
deficit/hyperactivity disorder. Arch Pediatr Adolesc Med
166(4):387–388
Nigg J, Nikolas M, Burt SA (2010) Measured gene-by-environment
interaction in relation to attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry 49(9):863–873
Oades RD (2011) An exploration of the associations of pregnancy and
perinatal features with cytokines and tryptophan/kynurenine
metabolism in children with attention-deficit hyperactivity
disorder (ADHD). Atten Defic Hyperact Disord 3(4):301–318
Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG,
Schwarz MJ (2010) Attention-deficit hyperactivity disorder
(ADHD) and glial integrity: an exploration of associations of
cytokines and kynurenine metabolites with symptoms and
attention. Behav Brain Funct 6:32
Overmeyer S, Bullmore ET, Suckling J, Simmons A, Williams SC,
Santosh PJ, Taylor E (2001) Distributed grey and white matter
deficits in hyperkinetic disorder: MRI evidence for anatomical
abnormality in an attentional network. Psychol Med
31(8):1425–1435
Owens EB, Hinshaw SP (2013) Perinatal problems and psychiatric
comorbidity among children with ADHD. J Clin Child Adolesc
Psychol 42(6):762–768
Peterson B, Anderson A, Ehrenkranz R, Staib L, Tageldin M, Colson
E, Gore J, Duncan C, Makuch R, Ment L (2003) Regional brain
volumes and their later neurodevelopmental correlates in term
and preterm infants. Pediatrics 111(5):939
Phua DY, Rifkin-Graboi A, Saw SM, Meaney MJ, Qiu A (2012)
Executive functions of six-year-old boys with normal birth
weight and gestational age. PLoS One 7(4):e36502
Pineda DA, Palacio LG, Puerta IC, Merchan V, Arango CP, Galvis
AY, Gomez M, Aguirre DC, Lopera F, Arcos-Burgos M (2007)
Environmental influences that affect attention deficit/hyperac-
tivity disorder: study of a genetic isolate. Eur Child Adolesc
Psychiatry 16(5):337–346
Poelmans G, Pauls D, Buitelaar J, Franke B (2011) Integrated
genome-wide association study findings: identification of a
neurodevelopmental network for attention deficit hyperactivity
disorder. Am J Psychiatry 168(4):365
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007)
The worldwide prevalence of ADHD: a systematic review and
metaregression analysis. Am J Psychiatry 164(6):942–948
Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin
JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA,
Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ,
Torrey EF, Bahn S (2004) Mitochondrial dysfunction in
schizophrenia: evidence for compromised brain metabolism
and oxidative stress. Mol Psychiatr 9(7):684–697
Rehn A, Van Den Buuse M, Copolov D, Briscoe T, Lambert G, Rees
S (2004) An animal model of chronic placental insufficiency:
relevance to neurodevelopmental disorders including
schizophrenia. Neuroscience 129(2):381–391
Ribases M, Hervas A, Ramos-Quiroga JA, Bosch R, Bielsa A,
Gastaminza X, Fernandez-Anguiano M, Nogueira M, Gomez-
Barros N, Valero S, Gratacos M, Estivill X, Casas M, Cormand B,
Bayes M (2008) Association study of 10 genes encoding neu-
rotrophic factors and their receptors in adult and child attention-
deficit/hyperactivity disorder. Biol Psychiatry 63(10):935–945
Roza SJ, Steegers EA, Verburg BO, Jaddoe VW, Moll HA, Hofman
A, Verhulst FC, Tiemeier H (2008) What is spared by fetal
brain-sparing? Fetal circulatory redistribution and behavioral
problems in the general population. Am J Epidemiol
168(10):1145–1152
Salmaso N, Jablonska B, Scafidi J, Vaccarino FM, Gallo V (2014)
Neurobiology of premature brain injury. Nat Neurosci
17(3):341–346
Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, Bosch R,
Boreatti-Hummer A, Heine M, Jacob CP, Lesch KP, Fasmer OB,
Knappskog PM, Kooij JJ, Kan C, Buitelaar JK, Mick E,
Asherson P, Faraone SV, Franke B, Johansson S, Haavik J, Reif
A, Bayes M, Cormand B (2010) Meta-analysis of brain-derived
neurotrophic factor p.Val66Met in adult ADHD in four Euro-
pean populations. Am J Med Genet B Neuropsychiatr Genet
153B(2):512–523
Schmidt-Kastner R, van Os J, Steinbusch H, Schmitz C (2006) Gene
regulation by hypoxia and the neurodevelopmental origin of
schizophrenia. Schizophr Res 84(2–3):253–271
Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP
(2012) An environmental analysis of genes associated with
schizophrenia: hypoxia and vascular factors as interacting
elements in the neurodevelopmental model. Mol Psychiatr
17(12):1194–1205
Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain.
Nat Rev Neurosci 5(6):437–448
Shibuya M (2008) Vascular endothelial growth factor-dependent and -
independent regulation of angiogenesis. BMBRep 41(4):278–286
Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF
receptors in regulation of angiogenesis and lymphangiogenesis.
Exp Cell Res 312(5):549–560
Skowronski K, Dubey S, Rodenhiser D, Coomber B (2010) Ischemia
dysregulates DNA methyltransferases and p16INK4a methyla-
tion in human colorectal cancer cells. Epigenetics 5(6):547–556
Smith TF, Anastopoulos AD, Garrett ME, Arias-Vasquez A, Franke
B, Oades RD, Sonuga-Barke E, Asherson P, Gill M, Buitelaar
JK, Sergeant JA, Kollins SH, Faraone SV, Ashley-Koch A,
Consortium I (2014) Angiogenic, neurotrophic, and inflamma-
tory system SNPs moderate the association between birth weight
and ADHD symptom severity. Am J Med Genet B Neuropsy-
chiatr Genet 165B(8):691–704
Sonuga-Barke EJ (2002) Psychological heterogeneity in AD/HD—A
dual pathway model of behaviour and cognition. Behav Brain
Res 130(1–2):29–36
Swanson JD, Wadhwa PM (2008) Developmental origins of child
mental health disorders. J Child Psychol Psychiatry
49(10):1009–1019
Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA,
Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD
(2007) Etiologic subtypes of attention-deficit/hyperactivity dis-
order: brain imaging, molecular genetic and environmental
factors and the dopamine hypothesis. Neuropsychol Rev
17(1):39–59
Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M,
Rutter M, Harold G (2009) Prenatal smoking might not cause
attention-deficit/hyperactivity disorder: evidence from a novel
design. Biol Psychiatry 66(8):722–727
Thapar A, Cooper M, Eyre O, Langley K (2013) What have we learnt
about the causes of ADHD? J Child Psychol Psychiatry
54(1):3–16
Thuring A, Marsˇa´l K, Laurini R (2012) Placental ischemia and
changes in umbilical and uteroplacental arterial and venous
hemodynamics. J Matern Fetal Neonatal Med 25(6):750
Todd RD, Botteron KN (2001) Is attention-deficit/hyperactivity
disorder an energy deficiency syndrome? Biol Psychiatry
50(3):151–158
Toft P (1999) Prenatal and perinatal striatal injury: a hypothetical
cause of attention-deficit–hyperactivity disorder? Pediatr Neurol
21(3):602–610
Tolsa C, Zimine S, Warfield S, Freschi M, Sancho R, Lazeyras F,
Hanquinet S, Pfizenmaier M, Huppi P (2004) Early alteration of
structural and functional brain development in premature infants
born with intrauterine growth restriction. Pediatr Res 56(1):132
Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N,
Sakamoto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ,
Takahama Y (2003) Defective brain development in mice
lacking the Hif-1alpha gene in neural cells. Mol Cell Biol
23(19):6739–6749
Tsai YP, Wu KJ (2013) Epigenetic regulation of hypoxia-responsive
gene expression: focusing on chromatin and DNA modifications.
Int J Cancer 134(2):249–256
Tylee D, Kawaguchi D, Glatt S (2013) On the outside, looking in: A
review and evaluation of the comparability of blood and brain-
‘‘omes’’. Am J Med Genet B Neuropsychiatr Genet
162(7):595–603
Ungethum U, Chen Y, Gross J, Bjelke B, Bolme P, Eneroth P, Heldt
J, Loidl CF, Herrera-Marschitz M, Andersson K (1996) Effects
of perinatal asphyxia on the mesostriatal/mesolimbic dopamine
system of neonatal and 4-week-old male rats. Exp Brain Res
112(3):403–410
van Os J, Wichers M, Danckaerts M, Van Gestel S, Derom C,
Vlietinck R (2001) A prospective twin study of birth weight
discordance and child problem behavior. Biol Psychiatry
50(8):593–599
Viswanathan G, Seto J, Patil S, Nudelman G, Sealfon S (2008)
Getting started in biological pathway construction and analysis.
PLoS Comput Biol 4(2):e16
Wadhwa PD, Buss C, Entringer S, Swanson JM (2009) Develop-
mental origins of health and disease: brief history of the
approach and current focus on epigenetic mechanisms. Semin
Reprod Med 27(5):358–368
Walhovd KB, Fjell AM, Brown TT, Kuperman JM, Chung Y, Hagler
DJ Jr, Roddey JC, Erhart M, McCabe C, Akshoomoff N, Amaral
DG, Bloss CS, Libiger O, Schork NJ, Darst BF, Casey BJ, Chang
L, Ernst TM, Frazier J, Gruen JR, Kaufmann WE, Murray SS,
van Zijl P, Mostofsky S, Dale AM, Pediatric Imaging,
Neurocognition, Study Group (2012) Long-term influence of
normal variation in neonatal characteristics on human brain
development. Proc Natl Acad Sci USA 109(49):20089–20094
Walker C, Anderson K, Milano K, Ye S, Tancredi D, Pessah I, Hertz-
Picciotto I, Kliman H (2013) Trophoblast inclusions are
significantly increased in the placentas of children in families
at risk for autism. Biol Psychiatry 74(3):204
Wang X, Meng FS, Liu ZY, Fan JM, Hao K, Chen XQ, Du JZ (2013)
Gestational hypoxia induces sex-differential methylation of
Crhr1 linked to anxiety-like behavior. Mol Neurobiol
48(3):544–555
Watson JA, Watson CJ, McCann A, Baugh J (2010) Epigenetics, the
epicenter of the hypoxic response. Epigenetics 5(4):293–296
Wheaton WW, Chandel NS (2011) Hypoxia 2. Hypoxia regulates
cellular metabolism. Am J Physiol Renal Physiol 300(3):C385–
C393
Whitaker A, Van Rossem R, Feldman J, Schonfeld I, Pinto-Martin J,
Tarre C, Shaffer D, Paneth N (1997) Psychiatric outcomes in
low-birth-weight children at age 6 years: relation to neonatal
cranial ultrasound abnormalities. Arch Gen Psychiatry
54(9):847–856
Whitaker AH, Feldman JF, Lorenz JM, McNicholas F, Fisher PW,
Shen S, Pinto-Martin J, Shaffer D, Paneth N (2011) Neonatal
head ultrasound abnormalities in preterm infants and adolescent
psychiatric disorders. Arch Gen Psychiatry 68(7):742–752
Wu X, Sun J, Li L (2013) Chronic cerebrovascular hypoperfusion
affects global DNA methylation and histone acetylation in rat
brain. Neurosci Bull 29(6):685–692
Yang L, Neale BM, Liu L, Lee SH, Wray NR, Ji N, Li H, Qian Q,
Wang D, Li J, Faraone SV, Wang Y, Psychiatric GCAS (2013)
Polygenic transmission and complex neuro developmental
network for attention deficit hyperactivity disorder: genome-
wide association study of both common and rare variants. Am J
Med Genet B Neuropsychiatr Genet 162B(5):419–430
Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R,
Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL
(1999) Impaired physiological responses to chronic hypoxia in
mice partially deficient for hypoxia-inducible factor 1alpha.
J Clin Invest 103(5):691–696
Zubrick S, Kurinczuk J, McDermott B, McKelvey R, Silburn S,
Davies L (2000) Fetal growth and subsequent mental health
problems in children aged 4 to 13 years. Dev Med Child Neurol
42(01):14–20
